Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1098 | 1146 | 1203 | 906 | 1578 | 1694 |
Fund Return | 9.81% | 14.59% | 20.32% | -3.24% | 9.56% | 5.41% |
Place in category | 9 | 21 | 53 | 289 | 41 | 82 |
% in Category | 2 | 5 | 16 | 76 | 15 | 39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Calamos Growth & Income A | 1.38B | 8.52 | 5.47 | 9.71 | ||
Calamos Growth & Income I | 1.25B | 8.63 | 5.73 | 9.98 | ||
Calamos Growth A | 1.18B | 14.06 | 6.40 | 11.31 | ||
Calamos Phineus Long/Short I | 922.5M | 7.04 | 1.80 | - | ||
Calamos Growth I | 345.07M | 14.21 | 6.68 | 11.59 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds Europacific Growth R | 66.75B | 8.14 | -2.08 | 5.44 | ||
Vanguard International Growth Adm | 38.11B | 8.82 | -5.85 | 7.87 | ||
American Funds Europacific Growth F | 21.11B | 8.10 | -2.18 | 5.33 | ||
American Funds Europacific Growth A | 20.52B | 7.99 | -2.44 | 5.07 | ||
WCM Focused International Growth I | 18.23B | 10.15 | -0.49 | 9.30 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.23 | 1,007.0 | -2.04% | |
ASML Holding | NL0010273215 | 3.87 | 946.60 | -0.38% | |
Advantest Corp. | JP3122400009 | 3.70 | 6,222.0 | +7.02% | |
Rolls-Royce Holdings | GB00B63H8491 | 3.48 | 461.70 | -0.92% | |
Shopify Inc | CA82509L1076 | 3.07 | 65.08 | +0.46% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review